![](/img/cover-not-exists.png)
BCNU as second line therapy for recurrent high-grade glioma previously treated with Temozolomide
Mark A Rosenthal, David L Ashley, Lawrence CherVolume:
11
Year:
2004
Language:
english
DOI:
10.1016/j.jocn.2003.01.002
File:
PDF, 54 KB
english, 2004